Second phase III trial of MED2002 for the Treatment of Erectile Dysfunction (ED)

Trial Profile

Second phase III trial of MED2002 for the Treatment of Erectile Dysfunction (ED)

Planning
Phase of Trial: Phase III

Latest Information Update: 14 Mar 2018

At a glance

  • Drugs Nitroglycerin (Primary)
  • Indications Erectile dysfunction
  • Focus Registrational; Therapeutic Use
  • Sponsors Futura Medical
  • Most Recent Events

    • 14 Mar 2018 According to a Futura Medical media release, Interim pharmacokinetic data indicates that at least two higher strength doses of MED2002 are eligible for the planned Phase III studies (this and profile 283164) compared with the dose used in the successful Phase II study.
    • 01 Dec 2017 New trial record
    • 29 Nov 2017 According to a Futura Medical media release, data from the PK study (profile 283168) will determine the dosages to be used in this and other trial (see profile 283164).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top